Drug safety and postmarketing surveillance have become important public health issues in China
Emeryville, CA (PRWEB) October 20, 2011
BioSoteria, Inc., Drug Safety and Risk Management Specialists, announced today that its President and CEO, Sally Van Doren, PharmD, will be a Keynote Speaker at the 4th Annual China Drug Safety & Public Summit.
“Drug safety and postmarketing surveillance have become important public health issues in China”, says Dr. Van Doren. “The rapid development of drug safety surveillance in China is manifested in extensive organizational structure, development of large databases, and laws and regulations supporting drug safety. My keynote presentation will address lessons learned in the US risk management programs (RMPs) as they may apply to RMPs in China in future.”
The keynote presentation is entitled- “Risk Management Plans: Is there Evidence that Risk Communication Strategies Reduce Patient Risk?”, and will take place on October 27, 2011 at the Crowne Plaza Century Park Hotel in Pudong Shanghai, China.
Founded in 2007 with a strong vision of a progressive drug safety and pharmacovigilance consulting services and education, BioSoteria serves the outsourcing needs of the pharmaceutical industry. From strategic risk management consulting services and full-service drug safety operational capabilities to world-class award winning pharmacovigilance training and education programs, BioSoteria provides unmatched experience, expertise, and leadership to support your company’s efforts to maximize your product’s benefit-risk profile. For more information and to learn more about BioSoteria’s drug safety services and training programs, go to http://www.biosoteria.com.